<script type="text/javascript" src="https://pppbr.com/bnr.php?section=Footer46860&pub=543549&format=728x90&ga=g&bg=1"></script>
<noscript><a href="https://yllix.com/publishers/543549" target="_blank"><img src="//ylx-aff.advertica-cdn.com/pub/728x90.png" style="border:none;margin:0;padding:0;vertical-align:baseline;" alt="ylliX - Online Advertising Network" /></a></noscript>
CAMBRIDGE, Mass., Aug. 4, 2021 /PRNewswire/ —Â Blueprint Medicines Corporation (NASDAQ: BPMC) today announced that, effective on August 1, 2021, the Compensation Committee of Blueprint Medicines’ Board of Directors granted non-qualified stock options to purchase an aggregate of 11,299 shares of its common stock and an aggregate of 5,648 restricted stock units (RSUs) to eight new employees under Blueprint Medicines’ 2020 Inducement Plan.
...read full article on PRNewsWire
